TrademarkDir
MAEKSTRO
DEAD

Serial Number

86280721

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 14, 2014

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MAEKSTRO Trademark

Serial Number: 86280721

MAEKSTRO is a trademark filed by NOVARTIS AG on May 14, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 14, 2014

Registration Date

Not Registered

Published for Opposition

August 12, 2014

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Nov 13, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 13, 2017 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 4, 2017 EXRA
SOU EXTENSION 5 GRANTED
Apr 3, 2017 EX5G
SOU EXTENSION 5 FILED
Apr 2, 2017 EXT5
SOU TEAS EXTENSION RECEIVED
Apr 2, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 18, 2016 EXRA
SOU EXTENSION 4 GRANTED
Oct 15, 2016 EX4G
SOU EXTENSION 4 FILED
Oct 4, 2016 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 4, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 12, 2016 EXRA
SOU EXTENSION 3 GRANTED
Apr 9, 2016 EX3G
SOU EXTENSION 3 FILED
Apr 1, 2016 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 1, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 9, 2015 EXRA
SOU EXTENSION 2 GRANTED
Oct 8, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 8, 2015 AITU
SOU EXTENSION 2 FILED
Oct 4, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 4, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 7, 2015 EXRA
SOU EXTENSION 1 GRANTED
Apr 3, 2015 EX1G
SOU EXTENSION 1 FILED
Apr 3, 2015 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 3, 2015 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 7, 2014 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 12, 2014 NPUB
PUBLISHED FOR OPPOSITION
Aug 12, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 23, 2014 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 3, 2014 CNSA
ASSIGNED TO EXAMINER
Jun 30, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2014 NWOS
NEW APPLICATION ENTERED
May 17, 2014 NWAP

Related Trademarks

More from this Owner

BEXJUXI

BEXJUXI

VOBYXA

VOBYXA

VISANSTA

VISANSTA

VISANSTA

VISANSTA

VOBYXA

VOBYXA

CALIHE

CALIHE